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onset and recovery of spinal cord ischemia
associated with aortic endografting
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Roy K. Greenberg, MD, Cleveland, Ohio
Objective: Spinal cord ischemia (SCI) is a devastating complication associated with aortic aneurysm repair. The aim of the
current study was to evaluate factors affecting outcomes from SCI associated with endovascular aortic aneurysm repair.
Methods: A total of 1251 patients underwent endovascular repair of aortic aneurysm as part of a device trial between 1998
and 2010 utilizing endovascular abdominal aortic aneurysm repair (n [ 351), thoracic endovascular aortic aneurysm
repair (n [ 201), fenestrated endovascular aortic aneurysm repair (n [ 227), and visceral branched endografts (n [
472). Records and imaging studies were reviewed to supplement prospective outcome data. Demographics, type of repair,
collateral bed (hypogastric/subclavian) patency, clinical presentation, and outcomes were evaluated on patients with SCI.
Survival was calculated using life-table analysis.
Results: SCI occurred in 2.8% (n [ 36) of patients: abdominal aortic aneurysm, 0.3%, juxtarenal, 0.4%, thoracic aortic
aneurysm, 4.6%, and thoracoabdominal aortic aneurysm, 4.8%). Four (11%) required carotid-subclavian bypass prior to
endografting, and two underwent coverage of the left subclavian artery. Unilateral hypogastric artery occlusion was
present in 11 (31%) patients prior to endograft placement, and three had bilateral occlusions. An additional seven patients
had occlusion of at least one hypogastric artery during surgery. SCI was apparent immediately in 15 (42%) patients.
Immediate onset of symptoms was observed in 73% of patients with at least one occluded collateral bed but in only 24% of
those with patent collateral beds (P[ .021). Of those presenting in a delayed fashion, nine (43%) had a clear precipitating
event prior to onset of SCI (hypotension, n [ 6, and segmental artery drain removal, n [ 3). Recovery occurred in 24
(67%) patients, most within 7 days. Immediate presentation was a negative predictor of recovery (P [ .025), as was
occlusion of at least one collateral bed (P[ .035). Mean follow-up was 22 6 4 months with 30-day and 1-year survival
of 92 6 4.6% and 56 6 8.3%. Survival was only 36% at 3 months in those with permanent SCI compared with 92%
(P < .001) in those with temporary symptoms.
Conclusions: SCI continues to complicate aortic surgery despite the advent of endovascular therapy. Occlusion of a single
collateral bed is associated with an increased risk for immediate onset of SCI and lack of recovery. These factors are
harbingers of poor outcomes and increased short-term mortality. This may be prevented by preserving collateral bed
patency in patients undergoing extensive endovascular procedures. (J Vasc Surg 2014;59:89-95.)Spinal cord ischemia (SCI) is a devastating complica-
tion associated with aortic surgery. The incidence of SCI
has been well documented following conventional open
surgery for abdominal aortic aneurysms (AAAs), thoracic
aortic aneurysms (TAAs), and thoracoabdominal aortic
aneurysms (TAAAs), and it occurs at an incidence
approaching 20% depending on the extent of the aorta that
is replaced and associated risk factors.1-4 Signiﬁcant effortsthe Department of Vascular Surgery, Cleveland Clinic Lerner College
Medicine.
or conﬂict of interest: Dr Eagleton has been paid consulting fees by
ook Medical (Bloomington, Ind). Dr Greenberg has been paid consul-
g fees and receives research funding from Cook Medical.
ented at the Plenary Session of the 2013 Vascular Annual Meeting of
e Society for Vascular Surgery, San Francisco, Calif, May 31, 2013.
rint requests: Matthew J. Eagleton, MD, Department of Vascular
rgery, H32, Cleveland Clinic Lerner College of Medicine-CWRU,
00 Euclid Ave, Cleveland, OH 44195 (e-mail: eagletm@ccf.org).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214/$36.00
yright  2014 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2013.07.007have been extended to understand the pathophysiology of
SCI. Based on these investigations, perioperative manage-
ment strategies have been developed to prevent its occur-
rence and lessen the untoward clinical impact, primarily
in patients with TAAAs. These adjuncts include the use
of permissive hypothermia, epidural cooling, cerebral spinal
ﬂuid drainage, left heart bypass, the use of intrathecal
papaverine, and reimplantation of intercostal vessels.3-7
These modalities either help to preserve cord function
through limiting the metabolic effects of SCI, or to pro-
mote increased perfusion through the spinal cord collateral
ﬂow network. Application of these efforts has allowed clini-
cians to signiﬁcantly reduce rates of SCI over the past
decade.
The development and broad application of endovascu-
lar technology has revolutionized the approach to treating
aortic disease. The use of this technology, however, has
not ameliorated the complication of SCI. Its incidence,
as would be expected, is rare in patients undergoing
endovascular abdominal aortic aneurysm repair (EVAR)8
and occurs at rates ranging from 2% to 10% following
thoracic endovascular aneurysm repair (TEVAR).9 The
evolution of fenestrated and branched aortic endograft89
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pair [FEVAR]) has allowed the extension of endovascular
treatment to more extensive aortic aneurysms including
TAAAs.10 Initial evaluation of rates of SCI in this popula-
tion suggests it occurs with a similar incidence as that of
conventional open surgery and is predicted mainly by the
extent of repair.2 The risks for the development of SCI
following endovascular surgery, however, may differ in
some ways from the development of this complication
following open surgery. Endovascular aneurysm repair
does not require aortic cross-clamping, which may be
protective. Endovascular surgery, however, requires more
manipulation within the aorta and does not allow for pres-
ervation of potentially important intercostal collaterals.
Evaluation of SCI that develops in these patients warrants
more intensive investigation as the pathophysiology of its
development, and the preventive and subsequent treatment
algorithms may differ signiﬁcantly from that of open
surgery.
The aim of this study was to evaluate the clinical
presentation of SCI that developed in patients undergoing
aortic endograft surgery for AAAs, TAAs, and TAAAs, and
to determine if any clinical parameters affected the timing
of presentation and clinical outcomes.
METHODS
All patients who underwent placement of an aortic
endograft under a physician-sponsored investigational
device exemption protocol between 1998 and 2010 were
included in this series (ClinicalTrials.gov Identiﬁers:
NCT00583817 (Endovascular Exclusion of Thoracic
Aortic Aneurysms, n ¼ 201), NCT00583050 (Endovascu-
lar Exclusion of TAAA/AAA Utilizing Fenestrated/
Branched Stent Grafts, n ¼ 699), and NCT00583414
(Endovascular Exclusion of Abdominal Aortic Aneurysms
in High-Risk Patients, n ¼ 351). These included patients
undergoing treatment with an infrarenal aortic endograft
(EVAR), thoracic aortic endograft (TEVAR), or a fenes-
trated/branched aortic endograft (FEVAR). Details of
the patient populations and methods of device implanta-
tion have been previously described.2,10,11 Patient medical
records and imaging studies were reviewed to supplement
prospective outcome data. Aneurysm type was assessed
using the Crawford classiﬁcation system.12 The protocol
for spinal cord drainage adhered to during this time period
has been previously described.2 Brieﬂy, spinal ﬂuid
drainage involved an initial pressure measurement followed
by continuous drainage to a pressure equivalent of 10 cm
H2O, which was begun during or at the conclusion of
the procedure. No limitations were set as to limiting the
volume of spinal ﬂuid drainage. The duration of spinal
drainage was at the discretion of the operating surgeon.
Type I, II, and III TAAAs were routinely drained; whereas
spinal drainage for type IV and TAA was at the discretion
of the operating surgeon. Demographics, type of repair,
vessel patency, clinical presentation, and outcomes were
evaluated on patients identiﬁed as having signs and symp-
toms consistent with SCI.Anatomic parameters were assessed using three-
dimensional reconstructions of contrast-enhanced comp-
uted tomographic (CT) scans on a TerRecon Aquarius
workstation (Version 4.4.6; TeraRecon, Inc, Foster City,
Calif). The maximum aneurysm diameter was measured
in a true orthogonal plane. Patency of subclavian and hypo-
gastric arteries, important contributors to the spinal cord
collateral blood supply network, was assessed and were
classiﬁed as patent or occluded; degrees of stenosis were
not classiﬁed. In addition, pre- and postoperative side-
branch patency, the presence of an endoleak, and technical
success were assessed using contrasted CT, intraoperative
arteriography, and/or duplex ultrasonography. Pre- and
postoperative imaging using magnetic resonance imaging
and/or angiography to assess for intercostal and lumbar
patency was not performed. The percent of aorta excluded
was calculated by ﬁrst determining the aortic length from
the left subclavian artery to the aortic bifurcation and
then determining the length of aorta excluded by both
the placement of the endograft and the total of the place-
ment of the endograft with any prior exclusion (by endog-
raft or open repair). For statistical assessment, aortic
exclusion was placed in groups of <50%, $50%, >75%,
or >90%.
Statistical analysis was performed using c2 analysis or
Fischer exact test. Survival analysis was performed using
life-table analysis with applications of the log-rank test
and Cox regression model. Statistical analysis was per-
formed using SigmaPlot 12.0 (Systat Software, Inc, San
Jose, Calif).
RESULTS
Lower extremity neurologic deﬁcits were identiﬁed
postoperatively in 92 patients undergoing aortic 1251
(7.4%) endograft procedures (Table I). All infrarenal
AAAs were treated with EVAR, whereas all juxtarenal
AAAs were treated with FEVAR. Fourteen TAAAs were
treated with FEVAR, 472 with branched endografts, and
seven with visceral vessel debranching followed by subse-
quent TEVAR coverage. This latter group was treated
prior to the incorporation of a branched endograft
program. TEVAR was used to treat 194 thoracic aortic
aneurysms. Of those presenting with lower extremity
neurologic deﬁcits, 36 (39%) were secondary to the devel-
opment of SCI. The remainder of neurologic deﬁcits were
attributed to cerebrovascular accident (n ¼ 19; 21%), acute
lower extremity ischemia (n ¼ 27; 29%), exacerbation of
a chronic neurologic comorbidity (n ¼ 5; 5%), peripheral
neuropathy (n ¼ 3; 3%), and metabolic encephalopathy
(n ¼ 1; 1%). The mean age of patients was 73 6 1.3 years
(range, 49-85), and 26 (72%) were male. Patient comor-
bidities included coronary artery disease (n ¼ 27; 76%),
hypertension (n ¼ 35; 97%), hyperlipidemia (n ¼ 27;
76%), pulmonary disease (n ¼ 22; 61%), current tobacco
use (18, 50%), cerebrovascular disease (n ¼ 13; 36%),
chronic renal insufﬁciency (n ¼ 11; 31%) with three (8%)
on hemodialysis prior to surgery, and diabetes (n ¼ 4;
11%). All but one of these patients had degenerative aortic
Table II. Incidence of spinal cord ischemia (SCI)
according to extent of endograft repair
Type of repair No. (%)
Incidence
SCI, No. (%)
Permanent
neurologic
defect,a No. (%)
Total 1251 (100) 36 (2.9) 11 (0.9)
Infrarenal AAA 351 (28) 1 (0.3) 1 (0.3)
Juxtarenal AAA 213 (17) 1 (0.5) 0 (0)
TAA 194 (16) 10 (5.2) 3 (1.5)
TAAA 493 (39) 24 (4.9) 7 (1.4)
Type I 18 (1.4) 4 (22) 1 (5.5)
Type II 93 (7.4) 9 (9.1) 3 (3.2)
Type III 136 (10.9) 6 (4.4) 2 (1.5)
Type IV 246 (19.7) 5 (2.0) 1 (0.4)
AAA, Abdominal aortic aneurysm; TAA, thoracic aortic aneurysm; TAAA,
thoracoabdominal aortic aneurysm.
aDeﬁned as the inability to ambulate independently.
Table III. Factors potentially associated with symptom
timing
Immediate
(n ¼ 15),
No. (%)
Delayed
(n ¼ 21),
No. (%)
P
value
Spinal drain use 9 (60) 18 (86) .122
Endoleak 4 (27) 7 (33) .729
Intraoperative hypotension 7 (47) 13 (62) .571
Prior aortic surgery 9 (60) 8 (38) .337
$50% aorta covered 7 (47) 16 (76) .657
$75% aorta covered 3 (20) 9 (43) .694
$1 collateral beds occluded 8 (73) 3 (14) .021
$2 collateral beds occluded 2 (13) 1 (5) .552
Table I. Type of endograft repairs
Type of endograft repair No. (%)
Total 1251 (100)
EVAR 351 (28)
TEVAR 201 (16)
FEVAR 227 (18)
Visceral branch 472 (38)
EVAR, Endovascular abdominal aortic aneurysm repair; FEVAR, fenes-
trated endovascular aortic aneurysm repair; TEVAR, thoracic endovascular
aortic aneurysm repair.
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aneurysmal degeneration of a chronic aortic dissection.
The overall rate of SCI was 2.9%, and the incidence
varied based on repair type (Table II). Mean aneurysm
size was 656 1.4 mm, and only one patient had a concom-
itant chronic aortic dissection. Seventeen (47%) had under-
gone prior aortic surgery at a contiguous or remote site
with 12 (33%) having had repair of an AAA and ﬁve
(14%) having had an aortic arch reconstruction with
elephant trunk graft. Nine (25%) patients had endograft
placement facilitated by placement of a conduit. Seven
(78%) conduits were placed at the time of endograft place-
ment, one of which was due to iliac artery rupture. Two
(22%) were placed in a staged setting at an antecedent
time. All subclavian arteries were widely patent preopera-
tively. Four (11%) of the patients required left carotid-
subclavian artery bypass to secure a sufﬁcient proximal
landing zone, all of which were performed prior to endog-
raft placement. Two (6%) patients required unplanned
coverage and subsequent occlusion of the left subclavian
artery during the repair, and they did not undergo subse-
quent revascularization. Eleven (31%) patients had at least
one occluded hypogastric artery prior to endograft place-
ment, three (8%) of which had bilateral occlusions. Addi-
tionally, seven (19%) patients had occlusion of at least
one hypogastric artery during endograft placement. All
endograft placements were considered technically success-
ful. Eleven patients (31%) were noted to have an endoleak
on completion aortography including two (5.5%) type I
endoleaks, six (16.6%) type II endoleaks, and three
(8.3%) type III endoleaks. Following endograft placement,
30 patients had sufﬁcient cross-sectional imaging to
measure the percent total aortic length excluded. The
mean percent of aortic length excluded was 67 6 3.8%
(range, 28%-100%).
The majority of patients (n ¼ 34; 94%) had their grafts
placed while under general anesthesia; the remaining two
surgeries were performed under epidural anesthesia. Spinal
drains were placed in 27 (75%) patients prior to the induc-
tion of anesthesia, and seven patients had spinal drains
placed postoperatively at the time of identiﬁcation of
neurologic symptoms. Two patients underwent an unsuc-
cessful attempt at spinal drain placement. Intraoperative
hypotension (deﬁned as an episode of systolic blood pres-
sure less than 90 mm Hg) occurred in 20 (55%) patients,
and 22 (61%) patients required the use of pressor agentsintraoperatively. The remainder of the patients was
managed with volume infusion. The mean volume of
intraoperative crystalloid infusion was 4279 6 360 (range,
1500-8200) mL, and 23 (64%) patients required a transfu-
sion with a mean volume of 970 6 193 transfused. Intra-
operative hypothermia (temperature <35

C) was observed
in only ﬁve (14%) patients.
Symptoms of SCI were identiﬁable immediately on
arousal from anesthesia in 15 (42%) patients. The remain-
ing patients presented in a delayed fashion with one
(2.8%) patient presenting 9 hours following surgery, eight
(22%) presenting $24 hours following surgery, and 12
(33%) presenting $48 hours following surgery (range,
2-10 days), with ﬁve of these patients presenting beyond
4 days postoperatively. The only factor associated with
early onset of symptoms was the presence of at least one
collateral bed occlusion (Table III). The immediate onset
of symptoms was observed in 73% of patients with at least
one occluded subclavian or hypogastric artery, whereas it
was only 24% in those patients with patent collateral beds
(P ¼ .021). Two patients that presented with immediate
onset, however, had evidence of diffuse embolization
following surgery (one AAA and one type III TAAA). Of
those presenting in a delayed fashion, nine (43%) had a
Fig 1. Graphic representation of actuarial survival for patients that underwent aortic endografting and developed
postoperative spinal cord ischemia (SCI).
Table IV. Factor affecting survival
HR (95% CI) P value
Immediate-onset
symptoms
0.0376 (0.00223-0.634) .023
Endoleak 0.430 (0.0803-2.298) .323
>50% aorta covered 0.146 (0.0116-1.834) .136
>75% aorta covered 4.275 (0.618-29.552) .141
All collateral beds patent 0.0626 (0.00675-0.581) .015
Improved symptoms 0.0262 (0.00182-0.376) .007
CI, Conﬁdence interval; HR, hazard ratio.
JOURNAL OF VASCULAR SURGERY
92 Eagleton et al January 2014clear precipitating event prior to the onset of symptoms
including an episode of hypotension (n ¼ 6) and segmental
artery (SA) drain removal (n ¼ 3). Hypotension was due to
hemodialysis (n ¼ 2), gastrointestinal bleeding (n ¼ 1),
cardiac dysrhythmia (n ¼ 1), or unidentiﬁable etiology
(n ¼ 2). Seventeen (47%) patients presented with sensory
deﬁcits, all of whom had bilateral symptoms; whereas 33
(92%) presented with motor deﬁcit of which 23 (64%)
were bilateral deﬁcits. Of the motor deﬁcits, 20 (61%)
were paraparesis, 12 (36%) were paraplegia, and 1 (3%)
was a mixed presentation.
Symptoms of SCI were managed in a variety of fashions
depending on the clinical scenario. Blood pressure was
augmented with either volume resuscitation or the use of
pressor agents to achieve a mean arterial pressure greater
than 90 mm Hg. If a spinal drain was in place at the
time, the threshold for drainage was lowered to less than
10 cm H2O. If a spinal drain was not intact and patients
did not respond to pressure augmentation, a spinal drain
was replaced. Twenty-four (67%) of the patients had
recovery from their symptoms. Of these, 21 (88%) had
resolution of all symptoms within 7 days of onset. In addi-
tion, all of the three remaining patients had residual weak-
ness but were ambulating independently at follow-up.
Three (25%) of the 12 that did not have improvement in
symptoms died during hospitalization. Of those patients
presenting in a delayed fashion, 18 (82%) had recovery
from their deﬁcits, whereas only seven (47%) of those
with immediate onset of SCI had improvement (P ¼
.025). In addition, those patients with at least one
occluded collateral bed had a lower rate of recovery from
symptoms compared with those with patent collateral
beds (45% vs 86%; P ¼ .035). Mean follow-up was 22 6
3.6 months (2 days-82 months). Survival for this group
at 30 days, 1 year, and 3 years is 92% (standard error
[SE] ¼ .046), 56% (SE ¼ .083), and 45% (SE ¼ .088),
respectively (Fig 1). Freedom from aneurysm-related
mortality was 92% (SE ¼ .024), 86% (SE ¼ .043), and86% (SE ¼ .053) at 30 days, 3 months, and 3 years, respec-
tively. Survival was affected by the time of onset of SCI,
the presence of all collateral beds remaining patent, and
resolution/improvement in symptoms (Table IV; Fig 2).
Of those patients discharged from the hospital, the maj-
ority of deaths within the ﬁrst 6 months were related to
pulmonary- (45%) or cardiac-related (36%) complications.
DISCUSSION
SCI remains a devastating complication of aortic
surgery in the endovascular era. The rate of development
directly correlates with the location and extent of aorta
that is excluded during endovascular repair.2 The risk of
SCI following EVAR is relatively low. In this series, SCI
developed in 0.3% of high-risk patients undergoing
EVAR. This is similar to the rates reported from the Euro-
star database of 0.21%.8 Based on the Eurostar analysis, the
development of SCI following EVAR has been associated
with peripheral embolization (as was observed in the sole
case of SCI following EVAR in this series), long procedure
times, extensive graft manipulation, and hypogastric artery
occlusion. These ﬁndings are further exempliﬁed in
ruptured AAAs in which SCI develops at a rate of 12%,
with patients having hypogastric artery occlusion, long
aortic occlusion times, and hypotension at increased risk.13
Fig 2. Graphic representation of survival curves for those patients
with spinal cord ischemia (SCI) who had improvement in symp-
toms (solid line) and those that did not improve (dotted line).
Survival for these two groups differed signiﬁcantly (log-rank test;
P < .0001). Survival at 30 days and 3 months was 100% and 92%
(standard error [SE] ¼ 0.054) for those who had improved
symptoms compared with 73% (SE ¼ 0.134) and 36% (SE ¼
0.145) for those that did not.
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and represented the etiology in only two of the 36 cases
represented in this series.
Aside from the rare event of diffuse atheroemboliza-
tion, SCI develops secondary to diminution of blood
ﬂow to the spinal cord. During conventional surgery, this
could be overcome with a number of modalities including
hypothermia, which decreases the metabolic requirements
of the neural tissue, the avoidance of steal by cross-
clamping bleeding intercostal arteries, and providing distal
aortic perfusion during aortic cross-clamping. These efforts
are further augmented by the ability to directly reimplant
intercostal vessels.14 These modalities are not possible
during endovascular therapy, and thus, an alternate
approach to preserving spinal cord integrity must be
sought. Efforts to maintain adequate spinal cord perfusion
pressure throughout the operation can be made through
the use of systemic pressure augmentation and by keeping
intrathecal pressures low through the use of cerebrospinal
ﬂuid drainage. These are frequently employed during
endovascular aneurysm repair of TAAs and TAAAs. While
the use of intrathecal papaverine has recently been
described as an adjunctive protective measure, it had not
been applied to the patients in this series, but its use has
since been employed.7
Similarly, important is the preservation of the collateral
network supplying the spinal cord. For years, it was be-
lieved that the best method to prevent SCI following
extensive aortic surgery was to preserve ﬂow through the
artery of Adamkiewicz, a supposed critical SA. Recent eval-
uation, however, has questioned the existence of a solitary
important artery. Instead, it is now understood that spinal
cord circulation is part of a continuous network that
includes the intercostal, lumbar, subclavian, and hypogas-
tric arteries, which provide ﬂow to the anterior spinal
artery.15,16 The anterior spinal artery is only onecomponent of an extensive paraspinal and intraspinal collat-
eral vascular network.16 In fact, within 24 hours of sacriﬁce
of all SAs in a porcine model, the anterior spinal artery
dilates, and within 5 days postligation, the anterior spinal
artery and epidural arterial network enlarges in diameter
by nearly 100%.17
Data from the current study highlight the importance
of the alternate routes of inﬂow into the collateral network
for preserving spinal perfusion following endovascular
aortic repair. Endovascular therapy mandates the cessation
of aortic inﬂow into the intercostal and/or lumbar arteries,
important components of the collateral network. In this
series, we were not able to reliably determine the pre-
and postoperative patency of the intercostal and lumbar
arteries. We do know, however, that aortic inﬂow into
these vessels is occluded with placement of a stent graft.
In this setting, if an additional insult is provided with the
occlusion of a solitary hypogastric artery or subclavian
artery, this further disrupts the collateral ﬂow sufﬁciently
to induce a more rapid onset of ischemic symptoms and
the inability to adequately recover from the insult. This
hypothesis is supported by data from the European
Registry on Endovascular Aortic Repair Complications
registry.18 Extensive coverage of intercostal arteries by
TEVAR alone was not associated with symptomatic SCI,
as sacriﬁce of one collateral bed was irrelevant. Simulta-
neous closure of at least two supplying vascular territories
was highly relevant with development of SCI, in particular
if it was associated with intraoperative hypotension.
Efforts to reduce the untoward effects of spinal cord
malperfusion may be achieved by preserving ﬂow (or
restoring ﬂow) to occluded subclavian and hypogastric
collaterals prior to extensive endovascular aortic coverage.
This may not always be possible. Given this, alternate
approaches should be sought to limit the risk and severity
of SCI. There is some suggestion in the literature that
staged repair of extensive aneurysms may help to reduce
this risk. Extensive SA sacriﬁce in a single operation in
a porcine model was associated with a paraplegia rate of
40%, and this did not occur in animals in which SAs were
sacriﬁced in a staged fashion.19 Assessments of spinal
cord perfusion pressure demonstrated that a two-stage
approach lead to only a mild drop in perfusion pressure
compared with the single-stage ligation. Similar results
have been demonstrated when SA occlusion in the thoracic
aorta was performed with the placement of a thoracic aortic
endograft.20 While this approach has yet to be reported on
in a prospective analysis, retrospective analysis of patients
undergoing two-staged vs single-staged approaches to treat
extensive TAAAs suggests a multistaged approach may be
associated with a reduced incidence of SCI.21 Given these
ﬁndings, we have begun to assess the utility of a staged
endovascular approach to treat extensive TAAA, as it may
provide an additional tool to limiting this complication.
One of the main limitations of this analysis is the
small sample size. Given such, it is unreliable to interpret
multivariable analysis, and thus, this was not performed.
In addition, assessment of SCI was not performed using
JOURNAL OF VASCULAR SURGERY
94 Eagleton et al January 2014the recommended standards outlined in Fillinger et al12
One of the difﬁculties in using the deﬁned scoring system
for SCI severity is that temporal changes were not
accounted for; it is not clear at what point in time (ie,
presentation vs date of discharge) the degree of severity
should reﬂect. Future evaluations by our team will assess
the degree of severity and speciﬁc temporal changes in
the degree of severity, using this scoring system. In addi-
tion, retrospective evaluation of intercostal and lumbar
artery patency was not reliably discernible on our perioper-
ative CT scans. While we can be sure that antegrade ﬂow
into the intercostals covered with an endograft was ablated,
we cannot assess whether these vessels remain patent or to
what extent occlusion of them occurs. Future prospective
studies will be aimed at assessing collateral network ﬂow
in the perioperative period on these complex endovascular
patients.
AUTHOR CONTRIBUTIONS
Conception and design: ME, RG, TM
Analysis and interpretation: ME, RG, TM, SS, DP
Data collection: ME, SS, DP
Writing the article: ME, RG, SS, TM, DP
Critical revision of the article: ME, TM
Final approval of the article: ME, TM, RG, DP, SS
Statistical analysis: ME
Obtained funding: RG
Overall responsibility: ME
REFERENCES
1. Coselli JB, Bozinovski J, Lemaire SA. Open surgical repair of 2286
thoracoabdominal aortic aneurysms. Ann Thorac Cardiovasc Surg
2007;83:S862-4.
2. Greenberg RK, Lu Q, Roselli EE, Svensson LG, Moon MC,
Hernandez AV, et al. Contemporary analysis of descending thoracic
and thoracoabdominal aneurysm repair: a comparison of endovascular
and open techniques. Circulation 2008;118:808-17.
3. Cambria RP, Davison JK. Regional hypothermia with epidural cooling
for spinal protection during thoracoabdominal aneurysm repair. Semin
Vasc Surg 2000;13:315-24.
4. Saﬁ HJ, Miller CC III, Huynh TT, Estrera AL, Porat EE,
Winnerkvist AN, et al. Distal aortic perfusion and cerebrospinal ﬂuid
drainage for thoracoabdominal and descending thoracic aortic repair:
ten years of organ protection. Ann Surg 2003;238:372-80; discussion:
380-1.
5. Svensson LG, Patel V, Robinson MF, Ueda T, Roehm JO Jr,
Crawford ES. Inﬂuence of preservation or perfusion of intraoperatively
identiﬁed spinal cord blood supply on spinal motor evoked potentials
and paraplegia after aortic surgery. J Vasc Surg 1991;13:355-65.
6. Coselli JS, LeMaire SA, Koksoy C, Schmittling ZC, Curling PE.
Cerebrospinal ﬂuid drainage reduces paraplegia after thoracoabdominal
aortic aneurysm repair: results of a randomized clinical trial. J Vasc Surg
2002;35:631-9.7. Lima B, Nowicki ER, Blackstone EH, Williams SJ, Roselli EE,
Sabik JF III, et al. Spinal cord protective strategies during descending
and thoracoabdominal aortic aneurysm repair in the modern era: the
role of intrathecal papaverine. J Thorac Cardiovasc Surg 2012;143:
945-952.e1.
8. Berg P, Kaufmann D, van Marrewijk CJ, Buth J. Spinal cord ischemia
after stent graft treatment for infrarenal abdominal aortic aneurysms.
Analysis of the Eurostar database. Eur J Vasc Endovasc Surg 2001;22:
342-7.
9. Buth J, Harris PL, Hobo R, van Eps R, Cuypers P, Duijm L, et al.
Neurologic complications associated with endovascular repair of
thoracic aortic pathology: Incidence and risk factors: a study from the
European Collaborators on Stent/Graft Techniques for Aortic Aneu-
rysm Repair (EUROSTAR) registry. J Vasc Surg 2007;46:1103-10;
discussion: 1110-1.
10. Greenberg R, Eagleton M, Mastracci T. Branched endografts for
thoracoabdominal aneurysms. J Thorac Cardiovasc Surg 2010;140(6
Suppl):S171-8.
11. Mastracci TM, Greenberg RK, Hernandez AV, Morales C. Deﬁning
high risk in endovascular aneurysm repair. J Vasc Surg 2010;51:
1088-95.
12. Fillinger MF, Greenberg RK, McKinsey JF, Chaikof EL. Reporting
standards for thoracic endovascular aortic repair (TEVAR). J Vasc Surg
2010;52:1022-33.
13. Peppelenbosch AG, Vermeulen Windsant IC, Jacobs MJ, Tordoir JH,
Schurink GW. Open repair for ruptured abdominal aortic aneurysm
and the risk of spinal cord ischemia: review of the literature and risk-
factor analysis. Eur J Vasc Endovasc Surg 2010;40:589-95.
14. Bischoff MS, Di Luozzo G, Griepp EB, Griepp RB. Spinal cord pres-
ervation in thoracoabdominal aneurysm repair. Perspect Vasc Surg
Endovasc Ther 2011;23:214-22.
15. Griepp R, Griepp EB. Spinal cord perfusion and protection during
descending thoracic and thoracoabdominal aortic surgery: the collateral
network concept. Ann Thorac Surg 2007;83:S865-9.
16. Etz CD, Kari FA, Mueller CS, Silovitz D, Brenner RM, Lin HM, et al.
The collateral network concept: a reassessment of the anatomy of spinal
cord perfusion. J Thorac Cardiovasc Surg 2011;141:1020-8.
17. Etz CD, Kari FA, Mueller CS, Brenner RM, Lin HM, Griepp RB. The
collateral network concept: remodeling of the arterial collateral
network after experimental segmental artery sacriﬁce. J Thorac Car-
diovasc Surg 2011;141:1029-36.
18. Czerny M, Eggebrecht H, Sodeck G, Verzini F, Cao P, Maritati G,
et al. Mechanisms of symptomatic spinal cord ischemia after TEVAR:
insights from the European Registry of Endovascular Aortic Repair
Complications (EuREC). J Endovasc Ther 2012;19:37-43.
19. Zoli S, Etz CD, Roder F, Brenner RM, Bodian CA, Kleinman G, et al.
Experimental two-stage simulated repair of extensive thor-
acoabdominal aneurysms reduces paraplegia risk. Ann Thorac Surg
2010;90:722-9.
20. Bischoff MS, Scheumann J, Brenner RM, Ladage D, Bodian CA,
Kleinman G, et al. Staged approach prevents spinal cord injury in
hybrid surgical-endovascular thoracoabdominal aortic aneurysm repair:
an experimental model. Ann Thorac Surg 2011;92:138-46.
21. Etz CD, Zoli S, Mueller CS, Bodian CA, di Luozzo G, Lazala R, et al.
Staged repair signiﬁcantly reduces paraplegia rate after extensive thor-
acoabdominal aortic aneurysm repair. J Thorac Cardiovasc Surg
2010;139:1464-72.Submitted May 18, 2013; accepted Jul 10, 2013.DISCUSSIONDr Amy Reed (Hershey, Pa). It was interesting to see some of
those that presented several days after the operation. Can you just
go over what you did to manage those patients?
Dr Matthew J. Eagleton. Our treatment strategy for all of
these patients was pretty much the same. The majority of thepatients that developed spinal cord ischemia late did so in associa-
tion with an episode of hypotension, and so the immediate
response was to augment their blood pressure either with ﬂuid
resuscitation or the use of pressors, and all of them had a spinal
drain replaced.
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that developed symptoms as their spinal drain was capped or
removed, but otherwise were physiologically normal, and regain
the neurologic function with replacement of the drain. I do not
have a good treatment strategy for those other than to try to main-
tain a high blood pressure and keep addressing the spinal drain
until you can take it out and be sure that they are not going to
develop a neurologic deﬁcit.
Dr Peter Gloviczki (Rochester, Minn). It is an important
problem, and seeing your honest results of a 22% paraplegia rate
in type II is telling me that we have not made really much progress
in this ﬁeld yet, although the number of your patients in this group
is small.
I am wondering if you know the anatomy of the spinal cord
blood supply in your patients and whether the fact that they
already had an occluded anterior spinal cord artery plays a role?
Dr Eagleton. The spinal cord ischemia rate was 22% in type I
thoracoabdominal aortic aneurysms, it was only 10% in type II
thoracoabdominal aortic aneurysms. We do not know the
anatomy. We attempted to retrospectively evaluate whether we
could identify on preoperative CT scanning important intercostals
that may have been occluded or patent pre-operatively, and then
assess their status postoperatively. And despite high-resolution
CT scanning, our ﬁndings were inconsistent.
Dr Gloviczki. And could you advise us if you have an aorta
where you already treated the proximal descending thoracic aorta,
you treated the abdominal aorta, and you see a large intercostal
artery, what should we do, should we do an endograft or an
open repair, an easy open repair?Dr Eagleton. I do not have a good answer to that. If it was an
easy open repair, those might be people that I would favor doing
an easy open repair in. Certainly, we counsel those patients who
undergo endograft repair that we are concerned about that vessel
and concerned about the risk for developing spinal cord ischemia.
We may be even more aggressive than we are about augmenting
blood pressure and being aggressive with spinal drainage during
the time period.
As I said, with endografting, though, we have to look for
other adjunctive measures that we can use, such as neuroprotec-
tive measures, and we are going to begin evaluating other things
such as the use of intrathecal papaverine or epidural cooling as
adjuncts that we can use to help supplement what we are already
doing.
Dr Mark Farber (Chapel Hill, NC). In your thoracic aneu-
rysm subset of patients, did you look at the location of the aneu-
rysm with respect to the celiac, whether the endografts were
placed down low in the bottom 5 to 8 cm above the celiac and
whether that impacted the results?
And the second question: Did you look at the chronicity of
your collateral bed occlusion? In other words, if someone has
a chronic left hypogastric occlusion, is that different than an acute
occlusion during the procedure in terms of whether they develop
spinal cord ischemia?
Dr Eagleton. For your ﬁrst question, no, we did not look at
the actual position of the thoracic endograft and its relationship to
the development of spinal cord ischemia. We did look, however, at
the chronicity. Unfortunately, the numbers become too small then
to show any statistical difference.
